Cargando…
Identification of novel drug targets for the risk and prognosis of COVID-19
BACKGROUND: Since the epidemic continues, there is a pressing need to improve our understanding of coronavirus disease 2019 (COVID-19). Mendelian randomization (MR) studies provide us with a method to explore the causality between circulating proteins and COVID-19 susceptibility and severity. We aim...
Autores principales: | Gan, Yi-Han, Ou, Ya-Nan, Yang, Yu-Xiang, Deng, Yue-Ting, Liu, Yi, Tan, Lan, Yu, Jin-Tai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263786/ https://www.ncbi.nlm.nih.gov/pubmed/35813330 http://dx.doi.org/10.21037/atm-21-6612 |
Ejemplares similares
-
Identification of a novel gene pairs signature in the prognosis of gastric cancer
por: Peng, Pai‐Lan, et al.
Publicado: (2017) -
Associations of cardiovascular risk factors and lifestyle behaviors with neurodegenerative disease: a Mendelian randomization study
por: Huang, Liang-Yu, et al.
Publicado: (2023) -
Identification and validation of a novel anoikis-related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma
por: Zhu, Yu-Ting, et al.
Publicado: (2023) -
Causal effects of serum sex hormone binding protein levels on the risk of amyotrophic lateral sclerosis: a mendelian randomization study
por: Ou, Ya-Nan, et al.
Publicado: (2022) -
Identifying causal genes for stroke via integrating the proteome and transcriptome from brain and blood
por: Wu, Bang-Sheng, et al.
Publicado: (2022)